Skip to main content
Man Group PLC logo

Man Group PLC — Investor Relations & Filings

Ticker · M3N ISIN · JE00BJ1DLW90 LEI · 2549003YWC1DW6LALB09 IL Financial and insurance activities
Open in API
Filings indexed 5,213 across all filing types
Latest filing 2021-09-03 Transaction in Own Shar…
Country JE Jersey
Listing IL M3N

About Man Group PLC

https://www.man.com/

Man Group PLC is an active investment management firm focused on delivering performance and client portfolio solutions. The company provides a range of alternative and long-only investment strategies across public and private markets for a global client base of institutional and high-net-worth investors. A key aspect of its approach is the integration of cutting-edge technology, quantitative expertise, and a data-driven culture to identify investment opportunities. The firm continuously invests in talent, technology, and research to manage capital for its clients, which include millions of savers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces 'Transactions in own shares' and details the purchase of ordinary shares as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The RNS Number and the reference to the London Stock Exchange confirm it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2021-09-03 English
Man Group PLC : Form 8.3 - Bally's Corporation
Major Shareholding Notification Classification · 97% confidence The document explicitly states it is a "FORM 8.3" which is a "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" under Rule 8.3 of the Takeover Code. This form details the interests and short positions of a party (Man Group PLC) in the securities of an offeror (Bally's Corporation) and an offeree (Gamesys Group plc) related to a takeover situation. This type of filing, concerning insider dealings or position disclosures during a takeover bid, does not fit neatly into the standard financial reporting categories (10-K, IR, ER). It is a specific regulatory disclosure related to corporate actions/takeovers. Among the provided codes, 'DIRS' (Director's Dealing) is related to insider transactions, but Form 8.3 is specifically tied to the Takeover Code and M&A activity. Since the core subject is a disclosure related to a takeover bid (Rule 8.3 of the Takeover Code), the closest relevant category is M&A Activity (TAR), although it is a disclosure *about* the parties involved in the M&A, rather than the M&A announcement itself. However, given the specific nature of insider dealing/position disclosure during a takeover, and the lack of a dedicated 'Takeover Disclosure' code, we must evaluate the closest fit. Director's Dealing (DIRS) covers personal share transactions by executives. This is a disclosure by a major shareholder/interested party during a takeover. Since the document is a specific regulatory filing concerning interests during a takeover, and it is not a general regulatory filing (RNS) or a general director dealing report (DIRS), we must check if it aligns with M&A Activity (TAR). TAR is defined as 'Announcements and documents related to merger proposals or takeover bids.' A Form 8.3 is a mandatory document *during* a takeover bid. Therefore, TAR is the most contextually appropriate classification, as it directly relates to the ongoing takeover process described by the form's purpose. If TAR is too broad, RNS (Regulatory Filings) would be the fallback, but TAR captures the specific context better.
2021-09-03 English
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
Director's Dealing Classification · 95% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013'. This form is used for 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of filing relates to insider transactions or significant changes in holdings during a takeover or related corporate action. Reviewing the provided definitions, none perfectly match a specific Irish Takeover Panel disclosure form. However, the content details personal share transactions by an executive/entity ('Man Group PLC/Jersey') in another company ('STRONGBRIDGE BIOPHARMA PLC') during a specific period, which strongly aligns with the concept of insider trading disclosure. The closest category that covers personal share transactions by directors/executives is 'Director's Dealing' (DIRS). While this is an Irish takeover filing, the core activity reported is a dealing disclosure, making DIRS the most appropriate fit among the given options, as it captures the essence of reporting insider transactions.
2021-09-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states 'Transactions in own shares' in the title and details the purchase of ordinary shares by Man Group plc as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The presence of the RNS Number and the closing statement about RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2021-09-02 English
Man Group PLC : Form 8.3 - Bally's Corporation
Major Shareholding Notification Classification · 98% confidence The document explicitly states it is a "FORM 8.3" which is a "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" under Rule 8.3 of the Takeover Code. This form details the interests and dealings of a party involved in a takeover bid (Bally's Corporation and Gamesys Group plc). This type of filing relates to insider transactions or significant ownership changes during a takeover process, which aligns most closely with insider trading/director dealings or general regulatory disclosures concerning transactions. Since there is a specific category for Director's Dealing (DIRS) and this involves reporting personal/firm transactions related to an offer, DIRS is the most appropriate fit, although it is specifically a Takeover Code disclosure. Given the options, DIRS covers personal share transactions by executives/directors, and this form reports significant share interests/dealings by Man Group PLC in relation to an offer. If DIRS is interpreted narrowly as only director's personal trades, then the general Regulatory Filings (RNS) might be considered. However, since it details specific security dealings (purchases/sales) by a major stakeholder during a takeover, it falls under the spirit of insider/significant transaction reporting. Comparing DIRS (Director's Dealing) and RNS (General Regulatory Filings), Form 8.3 is a mandatory disclosure related to transactions during a takeover. Given the provided definitions, DIRS is the closest fit for reporting specific security transactions/holdings by an interested party, even if it's not strictly a director. If we strictly adhere to the definitions, this is a specific regulatory filing about transactions, making RNS a strong fallback. However, Form 8.3 is fundamentally about disclosing interests/dealings in securities related to an offer. Let's re-evaluate the options: DIRS is for 'personal share transactions by company directors and executives (insider trades)'. This is a disclosure by Man Group PLC, not necessarily an individual director. Therefore, the most accurate general category for a specific, non-standard regulatory form detailing security interests/dealings during a corporate action (takeover) is the fallback, RNS (Regulatory Filings).
2021-09-02 English
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
M&A Activity Classification · 95% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL TAKEOVER RULES, 2013'. This form is used for 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' during a takeover situation. This type of filing relates to insider transactions or significant ownership changes during a specific corporate action (a takeover bid). Reviewing the provided definitions, the closest fit is 'Director's Dealing' (DIRS), as it concerns transactions by parties with interests in securities, although DIRS usually refers to standard insider trading reports (like Form 4 in the US). However, the document is specifically about dealings during a takeover bid involving STRONGBRIDGE BIOPHARMA PLC, which strongly aligns with M&A activity. The definition for M&A Activity (TAR) is 'Announcements and documents related to merger proposals or takeover bids.' Since this document is a mandatory disclosure related directly to a takeover process, TAR is the most appropriate classification, as it captures the context of the transaction better than DIRS (which is more general insider trading) or MRQ (which is general major shareholding notification).
2021-09-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.